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REPRODUCIBILITYOF ASSESSING KNEE PAIN
LOCALIZATION AND PATTERNS IN PARTICIPANTS FROM
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Purpose: To describe the location and pattern of knee pain in
patients with chronic frequent knee pain using the Knee Pain
Map; and to evaluate the inter- and intra-rater reliability of the
Knee Pain Map.
Methods: The Knee Pain Map is an interviewer-administered as-
sessment that characterizes knee pain as localized (i.e., patellar,
superior-medial, inferior-medial, medial joint line, superior-lateral,
inferior-lateral, lateral joint line), regional (medial, lateral, patellar
or back of the knee) or diffuse (or unable to localize). Partic-
ipants are allowed to identify more than one location of pain.
Localized pain is deﬁned by the use of one or two ﬁngers to
point to a speciﬁc location, whereas regional pain is deﬁned by
the use of the all the ﬁngers or the whole hand to cover a more
extensive region. Participants in this study were from the Univer-
sity of Pittsburgh Osteoarthritis Initiative (OAI) Clinical Center, a
community based cohort of men and women, ages 49-75, with
symptomatic knee OA or with risk factors that increase their
risk of developing knee OA. Prevalence of knee pain by loca-
tion and pattern is described for a convenience sample of 869
participants who reported knee pain during the past 12 months.
Inter-rater reliability was assessed in 24 participants by two ob-
servers who independently recorded the locations of knee pain
of a single participant at the same session. Intra-rater reliability
was assessed in 88 participants by having the same observer
administer the Knee Pain Map in two separate sessions. Inter-
and intra-rater reliability were calculated in Stata using Fleiss’s
kappa. For the inter-rater reliability, each participant was rated
by two of seven different raters and the kappa calculation was
structured to account for non-unique raters.
Results: Participants most often reported localized pain (75%)
followed by regional (18%) or diffuse (8%) pain. In those with
localized knee pain, the most commonly reported zones were
the medial joint line (57%), lateral joint line (44%), and patella
(37%). Pain was less commonly reported in the inferior-medial
area (7%), superior-lateral area (7%), inferior lateral area (6%)
and the back of the knee (6%). In those with regional knee pain,
the most commonly reported regions were the patella (44%) and
medial region (44%), while the lateral region (27%) and the back
of the knee (22%) were less commonly reported. A small group
of patients (9%) reported diffuse pain or were unable to localize
their pain.
There was excellent inter-rater reliability for identiﬁcation of lo-
calized and regional pain patterns (kappa = 0.7-0.9 and 0.7-0.8,
respectively). The inter-rater reliability for speciﬁc localized zones
was also excellent (kappa = 0.7-1.0) when the number of partici-
pants with pain in that zone (n) was > 5. When n 5 and 0.68-1.0
when n<5. For regional pain, the speciﬁc regions varied from
0.68-1.0.
Abstract 62 – Table 1
OA deﬁnitions Hypermobility Non-Hypermobility Odds 95% CI
(% OA affected) (% OA affected) Ratio*
Hand: Modiﬁed ACR criteria 2.6% 15.4% 0.15 0.02–1.12
Hand: Gogo criteria 2.6% 17.8% 0.12 0.02–0.94
Hand: Any single joint involvement by examination 18.4% 42.9% 0.30 0.30–0.71
Knee: ACR criteria 11.1% 34.4% 0.24 0.67–0.85
*Odds of OA compoaring hypermobility to non-hypermobility group; Hand OA data available for n=287; Knee OA data available for n=120.
Conclusions: We have successfully demonstrated a system to
identify and record the localization and pattern of pain in knee
OA with excellent reliability. Knee pain was most often described
as localized, with the medial and lateral joint lines as the most
commonly reported zones. Only a small minority of patients
reported diffuse pain or were unable to localize their knee pain.
Additional studies are needed to determine if speciﬁc knee pain
patterns or locations correlate with known risk factors for knee
OA or with areas of pathologic changes seen on x-rays or MRIs
in patients with knee OA.
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ASSOCIATION OF OSTEOARTHRITIS, OSTEOARTHRITIS
BIOMARKERS AND ARTICULAR HYPERMOBILITY
H-C. Chen, T. Stabler, V.B. Kraus
Duke University Medical Center, Durham, NC
Purpose: To date, no studies have evaluated the association of
articular hypermobility and osteoarthritis (OA) biomarkers. The
ﬁrst aim of this investigation was to evaluate the relationship
between hypermobility and OA biomarkers in a large extended
family. Secondly, we assessed the odds of developing OA in
subjects with hypermobility and non-hypermobility.
Methods: The GIAFD family, standing for Gene-Environment
Interactions in Aging, Functional Decline and Disease family,
is one of the most extensively pedigreed existing families in
the United States comprising nine generations originating from
one founder born in the 1700s. Ascertainment of 365 members
was accomplished at three reunions between 2002, 2004 and
2006, and included blood sampling and complete medical history
(n = 350), physician-performed hand examinations for OA and
hypermobility (n=287), and knee examinations for OA (n=120).
We employed several deﬁnitions of hand OA including modi-
ﬁed American College of Rheumatology (ACR) criteria, GoGo
(Genetics of Generalized Osteoarthritis) criteria, and any single
hand joint (either DIP or PIP or CMC) involvement on examina-
tion. Knee OA was deﬁned by ACR criteria. Participants were
considered as exhibiting hypermobility if they scored 4 or more
points out of 9 according to the criteria established by Beighton in
1973. The sera in 278 participants were available and assessed
for six OA-related biomarkers: PIIANP (LINCO), CPII (IBEX), C2C
(IBEX), Cartilage Oligomeric Matrix Protein or COMP (inhouse
assay with monoclonal antibodies 17C10 and 16F12 provided by
Dr. V Vilim), HA (Corgenix), and hs-CRP (MAGIWEL). Biomarker
data were natural logarithm (Ln) transformed. The odds and 95%
conﬁdence intervals (CI) of hand or knee OA were determined for
the hypermobility group relative to the non-hypermobility group.
Unpaired t tests were used to assess the mean biomarker con-
centrations and mean numbers of hand joints involved in the
hypermobility and non-hypermobility groups. A P-value of <0.05
was considered statistically signiﬁcant.
Results: Hypermobility (Beighton score≥4) was present in 38
(13.2%) of the 287 examined participants. The hypermobility
group was on average, 4 years younger (51.7±15.6 years) than
the non-hypermobility group (56.1±15.1 years), but this was not
signiﬁcantly different (p=0.10). Of the 6 biomarkers assessed,
only Ln serum COMP was signiﬁcantly different and lower in the
